The Chinese government halted the recommendation of an herbal supplement used as a traditional Chinese treatment for mild cases of COVID-19.
AstraZeneca’s Chinese operation is under intense scrutiny by the National Healthcare Security Administration of China over concerns about suspected medical insurance fraud perpetrated by company employees.
Heading into fall, with the Covid-19 pandemic surging again and researchers tracking new variants, there is plenty of news. BioSpace takes a look, including several research studies suggesting that some people have unusually strong immunity against Covid-19.
There are early signs that people who have been vaccinated against Covid-19 may be able to transmit the Delta variant of the virus as easily as those who have not, scientists at Public Health England (PHE) said on Aug. 6.
Two doses of Pfizer or AstraZeneca’s Covid-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study published on July 21 showed.
Although there have been discussions about using different Covid-19 vaccines in combination, World Health Organization (WHO) chief scientist Soumya Swaminathan warned against it, calling it a “dangerous trend.”
Britain said on July 7 the country would provide genomic sequencing support to Brazil, Ethiopia, Kenya, Nigeria and Pakistan to help identify, assess and track new variants of the novel coronavirus.
The Pfizer-BioNTech vaccine is highly effective against the Delta variant of Covid-19, a Pfizer official in Israel said on June 24.
Covid-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance remain broadly effective against Delta and Kappa variants of the Covid-19 causing virus that were first identified in India, according to a scientific study, underpinning a continued push to deliver the shots.
Medable Inc., a leading software platform for patient-centered drug development, announced a partnership with Aural Analytics in the company’s federally funded project to assess remote data capture and digital biomarkers in cancer patients.
